Evidence map›Paper›PMID 39677211›Full record

ArticleCureus2024

A Rare Case of Weil's Disease Presenting With Severe Hyperbilirubinemia and Acute Kidney Injury: A Diagnostic Challenge in Urban England.

Mohammed Ibrahim Salih Elfaki, Raumesha Biladiwala

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohammed Ibrahim Salih ElfakiInternal Medicine, Health Education England - North East, Newcastle-Upon-Tyne, GBR.
Raumesha BiladiwalaInternal Medicine, Northumbria Healthcare NHS Trust, Newcastle-Upon-Tyne, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a rare and challenging case of Weil's disease in a patient who was admitted to the Critical Care Unit with a clinical suspicion of the condition. The patient showed a prompt response to treatment before laboratory confirmation was obtained. Leptospirosis, a zoonotic disease, is most commonly found in tropical and temperate regions. While it is uncommon in the UK, it carries the potential for severe complications if not treated promptly. We report a 57-year-old gentleman from the North of England with no previous past medical history of note who presented with febrile illness and jaundice. His symptoms included fever, abdominal pain, and poor eating and drinking. Investigations showed raised inflammatory markers and deranged liver function tests (LFTs) with a hepatitic picture. Common causes of deranged LFTs including viral hepatitis, excessive alcohol intake, and paracetamol poisoning were excluded. In addition, CT abdomen and magnetic resonance cholangiopancreatography (MRCP) showed no obstructive lesions. He was admitted to the Intensive Treatment Unit (ITU) for monitoring due to impending multiorgan dysfunction. More elaborative history suggested leptospirosis, and he was treated empirically with intravenous ceftriaxone. Leptospira IgM and polymerase chain reaction (PCR) came back positive indicative of severe leptospirosis. He improved remarkably while in the ITU and was discharged to the ward and then home a few days later. In conclusion, we want to highlight leptospirosis as a cause of fulminant acute hepatitis with potential multiorgan failure and should be suspected even in urban regions when other common causes of hepatitis are excluded.

Indexed as

acute fulminant hepatitisfebrile jaundicehyperbilirubinaemiasevere leptospirosisweil's disease

Identifiers

PMID39677211
PMCPMC11646091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.